Uncovering news and insights
We’re constantly working to unlock new ideas that can drive progress. Here you’ll find research, data analysis, and expert perspectives to help you create better outcomes for your people.
Keeping medication costs manageable in a year of economic pressures
Despite inflation and price hikes across many commonly used drugs, the employer-sponsored insurance market continues to deliver meaningful stability – and even savings – thanks to strong cost management strategies.
When GLP-1s aren’t enough, lifestyle modification can be key to weight management.
As plan sponsors consider impactful ways to manage spend in 2024 and beyond, the power of drug optimization should not be overlooked.
The complex nature of copay assistance programs requires operational agility on the part of specialty pharmacies.
During the panel, experts discussed ways they have navigated patient recruitment challenges.
Plan sponsors should be aware of the effects the law will have on Medicare Part D over the coming years.
With GLP-1 sales forecast to exceed $100 billion, plan sponsors need the tools to control growth and expand access.
